Nicholas Investment Partners, LP Prometheus Biosciences, Inc. Transaction History

Nicholas Investment Partners, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$103.46 - $126.29 $1.07 Million - $1.31 Million	-10,336 Reduced 3.65%	272,910 $29.3 Million
Q4 2022 Feb 10, 2023	SELL	$36.06 - $117.21 $7.43 Million - $24.1 Million	-205,989 Reduced 42.1%	283,246 $31.2 Million
Q3 2022 Nov 14, 2022	SELL	$28.17 - $59.01 $1.18 Million - $2.48 Million	-42,058 Reduced 7.92%	489,235 $28.9 Million
Q2 2022 Aug 10, 2022	BUY	$22.39 - $38.94 $7.71 Million - $13.4 Million	344,213 Added 183.99%	531,293 $15 Million
Q1 2022 May 10, 2022	BUY	$30.13 - $50.0 $5.64 Million - $9.35 Million	187,080 New	187,080 $7.06 Million

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.